Loading...

VNRX VOLITIONRX LTD Capital Structure Changes 8-K Filing

VLTN

VNRX

VOLITIONRX LTD

(VNRX)

2026 8-K

Financial Results Announcement

Stock Issuances

Non-Compliance Notice

Funding Agreement Update

Management Change

Financial Results Update

Amended Underwriting Agreement

Offering Amendment

Stock Offering Update

Public Offering Details

Financial Results Announcement

Equity Offerings

Increase in authorized shares

Financial Statements

Share Sale Agreement

Stock Registration

Financial Results

Management Appointment

Director Appointment

Management Changes

Oncology Portfolio

Financial Results

Annual Meeting Approval and...

Earnings Reports

Financial Results and Busin...

Financing Round

Amendment to Stock Incentiv...

Agreement for Public Offering

External Links:

On January 7, 2026, VolitionRx Ltd entered into a funding agreement to receive $2M from Lind Global Asset Management in exchange for a convertible note worth $2.4M and warrants for 7,000,350 shares at $0.5714 each. This is in addition to a previous agreement signed on May 15, 2025, involving $7.5M in financing.

AI Assistant

VOLITIONRX LTD

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.